38
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Infliximab maintenance therapy for fistulizing Crohn's disease.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Infliximab, a monoclonal antibody against tumor necrosis factor, is an effective maintenance therapy for patients with Crohn's disease without fistulas. It is not known whether infliximab is an effective maintenance therapy for patients with fistulas.

          Related collections

          Author and article information

          Journal
          N Engl J Med
          The New England journal of medicine
          Massachusetts Medical Society
          1533-4406
          0028-4793
          Feb 26 2004
          : 350
          : 9
          Affiliations
          [1 ] Gastrointestinal Unit, Massachusetts General Hospital, and Harvard Medical School, Boston 02114, USA.
          Article
          350/9/876
          10.1056/NEJMoa030815
          14985485
          5197b614-07da-4a62-ab8b-3fe9bd6615bc
          Copyright 2004 Massachusetts Medical Society
          History

          Comments

          Comment on this article